CALR and cancer: As cancer cells develop distinct mechanisms to evade recognition by immune cells, one approach is to trigger the release and surface display of pro-immunogenic damage-associated molecular patterns (DAMPS), e.g., ATP, CRT, and HSPs, on dying cancer cells [45,46].